Quantitative Total Extensible Imaging (QTxI) vs Sepsis ImmunoScore
AI Verdict
Choose Quantitative Total Extensible Imaging (QTxI) if…
Choose Quantitative Total Extensible Imaging (QTxI) if your clinical practice requires advanced, quantitative analysis of medical images (CT and PET) for precise treatment monitoring, especially in oncology. This tool is ideal for evaluating changes in Regions of Interest over time, enabling detailed volumetric and metabolic assessments to track disease progression or response.
View Quantitative Total Extensible Imaging (QTxI) →Choose Sepsis ImmunoScore if…
Choose Sepsis ImmunoScore if your acute care setting needs a rapid, AI-driven diagnostic to assess sepsis risk and predict adverse outcomes. This tool is best suited for clinicians seeking to leverage EHR data for early identification and risk stratification of sepsis patients, enabling faster, more informed treatment decisions.
View Sepsis ImmunoScore →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Quantitative Total Extensible Imaging (QTxI) | Sepsis ImmunoScore |
|---|---|---|
| Pricing | Contact for pricing | Enterprise subscription model |
| Deployment | Cloud-based | Integrated into hospital EHR/EMR systems |
| FDA Status | 1 AI-estimated | 1 AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Sepsis ImmunoScoreTool B demonstrates superior usability through its direct integration into hospital EHR/EMR systems, minimizing workflow disruption. Its intuitive display transparently explains how parameters contribute to the sepsis score, fostering clinician trust and understanding, as validated by a human factors study.
Clinical Value
Sepsis ImmunoScoreTool B, as the 'first FDA-authorized AI diagnostic for sepsis,' addresses a highly time-sensitive and life-threatening condition with significant mortality rates. It provides both diagnostic and predictive power for critical adverse outcomes like mortality and ICU admission within 24 hours, offering immediate and impactful clinical utility.
Pricing & Value
TieBoth tools employ non-transparent, custom pricing models that require direct contact with the vendor. Without publicly available pricing details for either, it is impossible to conduct a head-to-head comparison of their cost-effectiveness or overall value proposition.
Enterprise Readiness
Sepsis ImmunoScoreTool B exhibits stronger enterprise readiness due to its seamless integration into existing hospital EHR/EMR systems and its exclusive distribution partnership with Roche Diagnostics. Furthermore, the establishment of a specific ICD-10-PCS code for AI sepsis diagnostic tools, including Sepsis ImmunoScore, streamlines documentation and reimbursement for hospitals.
Innovation
Sepsis ImmunoScoreTool B stands out as more innovative by being the 'first FDA-authorized AI diagnostic for sepsis,' representing a significant breakthrough in acute care. Its AI/ML SaMD approach leverages 22 diverse parameters to provide transparent, simultaneous diagnosis and prediction of multiple critical outcomes for a complex medical challenge.
Support & Docs
TieNeither the provided structured facts nor the web search results offer sufficient explicit detail regarding the specific customer support channels, service level agreements, or comprehensive documentation portals for either tool. While inferences can be made, a direct comparative judgment is not possible.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Quantitative Total Extensible Imaging (QTxI) | Sepsis ImmunoScore |
|---|---|---|
| Tool Name | Quantitative Total Extensible Imaging (QTxI) | Sepsis ImmunoScore |
| Company | AIQ Solutions | Prenosis |
| Description | FDA-cleared software tool for medical professionals to evaluate and manage digital medical images (DICOM CT and PET), enabling quantitative analysis of Regions of Interest for improved treatment monitoring, particularly in oncology. | First FDA-authorized AI diagnostic for sepsis, providing rapid risk assessment and prediction of adverse outcomes. It analyzes 22 parameters from EHRs to generate a risk score and four risk categories, aiding clinicians in faster treatment decisions and improved patient outcomes. |
| Primary Categories | Oncology AI, Radiology & Imaging AI | Clinical Decision Support & Reference, Triage & ER/ICU AI |
| Specialties | Nuclear Medicine, Oncology, Radiology | Critical Care, Emergency Medicine, Hospital Medicine |
| Key Features (Example) | Evaluation and information management of digital medical images (DICOM CT and PET) | First FDA-authorized AI diagnostic for sepsis |
Videos
Demos, reviews, and walkthroughs featuring Quantitative Total Extensible Imaging (QTxI) and Sepsis ImmunoScore.